E-cadherin (CDH1) gene-160C>a promoter polymorphism and risk of gastric and esophageal cancers


Akbas H., Uyanikoglu A., Aydogan T., ATAY A. E., Dilmec F., CERRAH S., ...Daha Fazla

Acta Medica Mediterranea, cilt.29, sa.4, ss.671-676, 2013 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2013
  • Dergi Adı: Acta Medica Mediterranea
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.671-676
  • Anahtar Kelimeler: CDH1 gene, E-cadherin, Esophageal cancer, Gastric cancer, Polymorphism
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Aim: The aim of this study was to investigate whether-160C>A single nucleotide polymorphism of the promoter region of the CDH1 gene (E-cadherin) is associated with gastric and esophageal cancers. Methods: Ninety-eight patients with gastric and esophageal cancers and 105 gender-and age-matched controls were enrolled in the study. Genotyping of CDH1-160C>A polymorphism (rs16260) was done by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: The CDH1-160C>A genotype and allele frequencies of the gastric and esophageal cancer patients did not differ significantly from those of healthy controls (p>0.05). With respect to tumour localization or histopathologic type, there was no significant association between CDH1-160C>A genotype with gastric or esophageal carcinomas. (p>0.05). Conclusion: The present study indicates that the CDH1gene-160C>A polymorphism is not associated with gastric and esophageal cancers in the Turkish population.